5,268 Shares in Marsh & McLennan Companies, Inc. $MRSH Purchased by Evolve Private Wealth LLC

Evolve Private Wealth LLC purchased a new position in shares of Marsh & McLennan Companies, Inc. (NYSE:MRSH) during the second quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor purchased 5,268 shares of the financial services provider’s stock, valued at approximately $878,000.

Other institutional investors and hedge funds have also made changes to their positions in the company. Farringdon Capital Ltd. purchased a new stake in Marsh & McLennan Companies in the 2nd quarter worth $328,000. W1M Asset Management Ltd purchased a new position in Marsh & McLennan Companies during the second quarter valued at $348,202,000. Varma Mutual Pension Insurance Co acquired a new stake in shares of Marsh & McLennan Companies in the second quarter valued at about $23,151,000. Westpac Banking Corp purchased a new stake in shares of Marsh & McLennan Companies during the second quarter worth about $990,000. Finally, Sumitomo Life Insurance Co. acquired a new position in shares of Marsh & McLennan Companies during the 2nd quarter worth about $637,000. 87.99% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Ratings Changes

MRSH has been the subject of several research reports. Wells Fargo & Company boosted their price objective on Marsh & McLennan Companies from $186.00 to $188.00 and gave the stock an “equal weight” rating in a research note on Wednesday, July 22nd. Mizuho lifted their price target on Marsh & McLennan Companies from $197.00 to $201.00 and gave the stock a “neutral” rating in a research note on Wednesday, July 22nd. Piper Sandler dropped their price target on Marsh & McLennan Companies from $190.00 to $182.00 and set a “neutral” rating for the company in a research report on Tuesday, May 26th. JPMorgan Chase & Co. raised their price objective on Marsh & McLennan Companies from $206.00 to $212.00 and gave the company an “overweight” rating in a report on Monday, July 13th. Finally, Weiss Ratings raised shares of Marsh & McLennan Companies from a “hold (c-)” rating to a “hold (c)” rating in a research note on Friday, August 7th. One research analyst has rated the stock with a Strong Buy rating, five have given a Buy rating, eleven have assigned a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat.com, the company currently has an average rating of “Hold” and an average target price of $203.50.

Insider Transactions at Marsh & McLennan Companies

In related news, insider Martin South sold 7,100 shares of the stock in a transaction on Tuesday, July 28th. The shares were sold at an average price of $189.99, for a total transaction of $1,348,929.00. Following the completion of the sale, the insider owned 16,632 shares in the company, valued at $3,159,913.68. This represents a 29.92% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, SVP Paul Beswick sold 713 shares of the firm’s stock in a transaction on Wednesday, July 29th. The stock was sold at an average price of $198.00, for a total transaction of $141,174.00. Following the transaction, the senior vice president directly owned 16,376 shares in the company, valued at $3,242,448. The trade was a 4.17% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold a total of 36,469 shares of company stock valued at $6,291,345 over the last quarter. Company insiders own 0.38% of the company’s stock.

Marsh & McLennan Companies Stock Performance

NYSE MRSH opened at $192.17 on Monday. The company has a debt-to-equity ratio of 1.22, a current ratio of 1.14 and a quick ratio of 1.14. The stock’s fifty day moving average is $179.88. The firm has a market capitalization of $91.71 billion, a price-to-earnings ratio of 23.49, a P/E/G ratio of 2.75 and a beta of 0.59. Marsh & McLennan Companies, Inc. has a fifty-two week low of $156.60 and a fifty-two week high of $212.65.

Marsh & McLennan Companies (NYSE:MRSH) last announced its quarterly earnings data on Tuesday, July 21st. The financial services provider reported $2.96 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.89 by $0.07. The business had revenue of $7.28 billion during the quarter. Marsh & McLennan Companies had a return on equity of 32.67% and a net margin of 14.24%.The company’s revenue was up 6.2% on a year-over-year basis. As a group, sell-side analysts forecast that Marsh & McLennan Companies, Inc. will post 10.43 EPS for the current year.

Marsh & McLennan Companies Increases Dividend

The company also recently announced a quarterly dividend, which was paid on Friday, August 14th. Stockholders of record on Thursday, July 23rd were given a dividend of $0.99 per share. This represents a $3.96 dividend on an annualized basis and a dividend yield of 2.1%. This is an increase from Marsh & McLennan Companies’s previous quarterly dividend of $0.90. The ex-dividend date was Thursday, July 23rd. Marsh & McLennan Companies’s payout ratio is presently 48.41%.

Marsh & McLennan Companies Profile

Marsh & McLennan Companies (NYSE: MMC) is a global professional services firm headquartered in New York City that provides advice and solutions in the areas of risk, strategy and people. Founded in 1905, the company has grown into a diversified group of businesses focused on insurance brokerage and risk management, reinsurance, human capital and investment consulting, and management consulting. Its long history and scale position it as a prominent adviser to corporations, governments and other institutions seeking to manage risk and optimize human and financial capital.

The firm operates through several well-known subsidiaries and business units that specialize in distinct services.